Apollo Medical director Michael Eng resigns effective Feb 15, 2023; no disagreement cited

Astrana Health, Inc.

Michael Eng notified the Board on Feb 2, 2023 of his resignation effective Feb 15, 2023.
Resignation is not the result of any disagreement with the Company's operations, policies, or practices.
No replacement for the departing director has been announced in this filing.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Eng

Director

ASTH · Astrana Health, Inc.

Effective: 2023-02-15
Filed: February 8, 2023, 6:59 PM ET

On February 2, 2023, Michael Eng notified the Board of Directors (the “Board”) of Apollo Medical Holdings, Inc. (the “Company”) of his decision to resign as a member of the Board effective as of February 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Eng resigned as Director at Astrana Health, Inc..

Action: resigned
Role: Director

Exact text from the filing

On February 2, 2023, Michael Eng notified the Board of Directors (the “Board”) of Apollo Medical Holdings, Inc. (the “Company”) of his decision to resign as a member of the Board effective as of February 15, 2023.

View on SEC.gov

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-014510

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.